Who Owns Altimmune Stock?
NASDAQ: ALTHealthcareBiotechnologyUSD
At close: Oct 9, 4:00 PM ET · Delayed 15 min
Ownership breakdown
- Held by institutions
- 77.86%
- Held by insiders
- 0.43%
- Institutional holders
- 274
- Institutions 77.9%
- Insiders 0.4%
- Public and other 21.7%
Who owns Altimmune stock?
Institutional investors own about 77.9% of Altimmune's shares, spread across 274 institutions that file 13F reports. That level of institutional ownership is high, typical of large, widely followed companies. Insiders, including executives, directors and large founding shareholders, hold 0.43% of ALT.
The largest institutional holders are Blackrock Inc. (10.48%), Deep Track Capital, Lp (9.90%) and State Street Corporation (6.22%). Together, the top 10 institutions control 52.6% of shares outstanding. In their latest filings, 10 of the top 10 institutions increased their ALT positions and 0 reduced them.
Summary generated from market data by MetaCap's automated system. Methodology
Top institutional holders of ALT
| Institution | Shares | % Held | Change |
|---|---|---|---|
| Blackrock Inc. | 20.39M | 10.48% | +59.3% |
| Deep Track Capital, Lp | 19.25M | 9.90% | +100.0% |
| State Street Corporation | 12.10M | 6.22% | +69.3% |
| TCG Crossover Management, LLC | 10.00M | 5.14% | +100.0% |
| Vanguard Capital Management LLC | 8.18M | 4.20% | +44.5% |
| Vanguard Portfolio Management LLC | 7.33M | 3.77% | +36.2% |
| Marshall Wace LLP | 6.84M | 3.52% | +70.3% |
| Viking Global Investors, L.P. | 6.70M | 3.44% | +100.0% |
| RA Capital Management, L.P. | 6.50M | 3.34% | +100.0% |
| Geode Capital Management, LLC | 5.01M | 2.58% | +61.3% |
% held is the share of total shares outstanding. Change is the percentage change in the position since the holder's previous 13F filing.
Top mutual fund and ETF holders of ALT
| Fund | Shares | % Held |
|---|---|---|
| SPDR SERIES TRUST-State Street SPDR S&P Biotech ETF | 8.55M | 4.39% |
| VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund | 5.75M | 2.96% |
| iShares Trust-iShares Russell 2000 ETF | 5.08M | 2.61% |
| VANGUARD HORIZON FUNDS-Vanguard Strategic Equity Fund | 2.52M | 1.30% |
| VANGUARD INDEX FUNDS-Vanguard Extended Market Index Fund | 2.24M | 1.15% |
| Fidelity Salem Street Trust-Fidelity Small Cap Index Fund | 2.17M | 1.12% |
| iShares Trust-iShares Russell 2000 Value ETF | 1.85M | 0.95% |
| Fidelity Covington Trust-Fidelity Enhanced Small Cap Core ETF | 1.45M | 0.75% |
| iShares Trust-iShares Biotechnology ETF | 1.37M | 0.70% |
| Vanguard Explorer Fund | 1.21M | 0.62% |
Frequently asked questions
Who is the largest shareholder of Altimmune?
Blackrock Inc. is the largest institutional shareholder of ALT, owning 10.48% of shares outstanding (20.39M shares) as of its latest 13F filing.
What percentage of Altimmune is owned by institutions?
Institutions own about 77.9% of ALT shares and 78.2% of the public float.
How much of Altimmune do insiders own?
Insiders, such as officers and directors, own about 0.43% of ALT shares outstanding.
Where does institutional ownership data come from?
Investment managers with more than $100 million in US equities must file Form 13F with the SEC within 45 days of each quarter-end. Holdings are therefore up to about 4.5 months old when published.